Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized-Controlled Trial of Semaglutide for Patients With Chronic Low Back Pain and Obesity

NCT07731256 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07731256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized-Controlled Trial of Semaglutide for Patients With Chronic Low Back Pain and Obesity
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
September 1, 2031
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lower back pain, glp1 agonist, lower back pain, obesity (bmi>30)